Translational Development Acquisition (TDAC) Cash & Equivalents (2023 - 2025)
Translational Development Acquisition's (TDAC) quarterly Cash & Equivalents came in at $29787.0 in Q4 2025, down 36.83% on a QoQ basis from $47150.0 in Q3 2025.
Translational Development Acquisition (TDAC) Cash & Equivalents (2023 - 2025) Analysis & Trends
Translational Development Acquisition (TDAC) has 2 years of Cash & Equivalents data on file, last reported at $29787.0 in Q4 2025.
- Quarterly Cash & Equivalents changed N/A year-over-year to $29787.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $29787.0 (changed N/A YoY) and the FY2025 annual result came in at $29787.0, changed N/A from the prior year.
- Cash & Equivalents slipped to $29787.0 in Q4 2025, from $47150.0 in the prior quarter.
- In the past five years, Cash & Equivalents ranged from a high of $47150.0 in Q3 2025 to a low of $2021.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oxley Bridge Acquisition | 585.76 Mn | 585.76 Mn | - | 816,134.00 |
| 2 | Launch Two Acquisition | 557.86 Mn | 557.86 Mn | - | 250,000.00 |
| 3 | Drugs Made In America Acquisition | 507.00 Mn | 507.00 Mn | - | 174,974.00 |
| 4 | Cantor Equity Partners IV | 468.00 Mn | 468.00 Mn | - | 25,000.00 |
| 5 | GP-Act III Acquisition | 401.06 Mn | 401.06 Mn | - | 10,586.00 |
| 6 | Aldel Financial | 397.49 Mn | 397.49 Mn | - | 283,112.00 |
| 7 | Republic Digital Acquisition | 389.25 Mn | 388.51 Mn | - | 735,027.00 |
| 8 | Gores Holdings X | 385.06 Mn | 384.87 Mn | - | 194,541.00 |
| 9 | Agriculture & Natural Solutions Acquisition | 377.29 Mn | 377.04 Mn | - | 250,000.00 |
| 10 | Translational Development Acquisition | 182.66 Mn | 182.57 Mn | - | 85,877.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 29,787.00 |
| Sep 30, 2025 | 47,150.00 |
| Jun 30, 2025 | 35,255.00 |
| Dec 31, 2023 | 2,021.00 |